The Brutalist Report

MarketWatch

• MarketWatch First Take: SoftBank’s Arm is going public, but it faces a rapidly growing threat [1008d]
• In One Chart: Workers are flying high in the sky, not jetting back to the office [1008d]
• The Tell: ETF that tracks Jim Cramer’s stock picks to close [1008d]
• : Pfizer maternal RSV vaccine gets FDA approval [1008d]
• Market Extra: U.S. stocks may bounce this week, but summer selloff is only halfway done, analysts warn [1008d]
• IPO Report: Chip designer Arm files for long-awaited IPO [1008d]
• The Ratings Game: Why Amazon is this analyst’s top internet stock pick [1008d]
• The Ratings Game: Adyen shares continue their meltdown as Morgan Stanley turns cautious [1008d]
• Market Extra: ETFs that buy Chinese stocks mired with losses after ‘measly’ rate cut in disappointing stimulus [1008d]
• The Ratings Game: Permian Resources building scale with $4.5 billion Earthstone Energy deal, analysts say [1008d]
• Earnings Results: Zoom’s stock pops 8% on strong earnings, guidance [1008d]
• The Fed: Jackson Hole meeting: When is Jerome Powell’s speech? What investors need to know. [1008d]
• In One Chart: Why investors are back to a ‘grab for yield,’ according to Mizuho strategist [1008d]
• Key Words: Grandson references ‘final chapter,’ but Carter Center observes that there has been no change in the health status of former president or first lady [1008d]
• : Brands like Bud Light and Target have always tried to embrace social causes. Here’s why they just can’t win. [1008d]